FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 104 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $70,962 | -52.7% | 24,899 | +20.9% | 0.00% | -100.0% |
| Q4 2022 | $149,953 | +14.5% | 20,598 | +27.1% | 0.00% | 0.0% |
| Q3 2022 | $131,000 | +67.9% | 16,212 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $78,000 | -75.9% | 15,983 | +17.1% | 0.00% | -50.0% |
| Q1 2022 | $323,000 | +25.2% | 13,645 | -6.6% | 0.00% | +100.0% |
| Q4 2021 | $258,000 | -37.2% | 14,606 | +0.2% | 0.00% | -50.0% |
| Q3 2021 | $411,000 | +216.2% | 14,583 | +17.5% | 0.00% | – |
| Q2 2021 | $130,000 | +11.1% | 12,411 | +25.0% | 0.00% | – |
| Q1 2021 | $117,000 | +20.6% | 9,926 | +19.3% | 0.00% | – |
| Q4 2020 | $97,000 | +42.6% | 8,319 | -2.8% | 0.00% | – |
| Q3 2020 | $68,000 | -51.4% | 8,557 | +11.9% | 0.00% | -100.0% |
| Q2 2020 | $140,000 | +57.3% | 7,650 | +2.3% | 0.00% | – |
| Q1 2020 | $89,000 | +89.4% | 7,481 | +163.1% | 0.00% | – |
| Q4 2019 | $47,000 | +147.4% | 2,843 | -0.8% | 0.00% | – |
| Q3 2019 | $19,000 | – | 2,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |